|
|
|
|
LEADER |
01417nam a2200241 u 4500 |
001 |
EB002219806 |
003 |
EBX01000000000000001356767 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
240703 r ||| eng |
245 |
0 |
0 |
|a MALDI-TOF mass spectrometry for pathogen identification
|h Elektronische Ressource
|b a review of accuracy and clinical effectiveness
|c prepared by Canadian Agency for Drugs and Technologies in Health
|
246 |
3 |
1 |
|a MALDI-TOF MS for pathogen identification
|
260 |
|
|
|a Ottawa (ON)
|b CADTH Rapid Response SErvice
|c 16 October 2015, 2015
|
300 |
|
|
|a 1 PDF file (65 pages)
|b illustration
|
505 |
0 |
|
|a Includes bibliographical references
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Rapid response report: peer-reviewed summary with critical appraisal
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK350093
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a This Rapid Response report reviews the accuracy and clinical impact of Matrix Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF) mass spectrometry (MS) for the identification of microbial pathogens. This report was reviewed by experts in clinical microbiology and bacteriology and mycology
|